12.01
price up icon26.29%   2.50
after-market After Hours: 11.95 -0.06 -0.50%
loading
Elanco Animal Health Inc stock is traded at $12.01, with a volume of 22.25M. It is up +26.29% in the last 24 hours and up +34.34% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$9.51
Open:
$10.83
24h Volume:
22.25M
Relative Volume:
4.27
Market Cap:
$4.71B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
30.02
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
+26.69%
1M Performance:
+34.34%
6M Performance:
-17.17%
1Y Performance:
-11.17%
1-Day Range:
Value
$10.75
$12.14
1-Week Range:
Value
$9.32
$12.14
52-Week Range:
Value
$8.02
$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Name
Elanco Animal Health Inc
Name
Phone
877-352-6261
Name
Address
2500 INNOVATION WAY, GREENFIELD
Name
Employee
9,450
Name
Twitter
@Elanco
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELAN's Discussions on Twitter

Compare ELAN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
12.01 4.71B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.99 69.76B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.06 48.12B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.76 45.75B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.60 20.17B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
306.92 13.67B 2.76B 1.11B 898.10M 22.77

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-24 Initiated UBS Buy
Dec-02-24 Initiated Leerink Partners Market Perform
Sep-19-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-05-24 Upgrade Stifel Hold → Buy
Dec-19-23 Initiated Jefferies Buy
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-23 Initiated Exane BNP Paribas Outperform
Apr-20-23 Upgrade Barclays Equal Weight → Overweight
Aug-18-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-16-22 Downgrade JP Morgan Overweight → Neutral
Jul-21-22 Downgrade Goldman Buy → Sell
Jul-12-22 Initiated Piper Sandler Neutral
Nov-18-21 Initiated Morgan Stanley Overweight
Oct-28-21 Downgrade Stifel Buy → Hold
Aug-05-21 Resumed Credit Suisse Outperform
Jun-15-21 Upgrade Cleveland Research Underperform → Neutral
May-11-21 Upgrade Barclays Underweight → Equal Weight
May-11-21 Upgrade Gabelli & Co Hold → Buy
Apr-15-21 Initiated Stifel Buy
Mar-22-21 Downgrade Gabelli & Co Buy → Hold
Feb-26-21 Upgrade Credit Suisse Neutral → Outperform
Dec-09-20 Downgrade Argus Buy → Hold
Nov-09-20 Downgrade Barclays Overweight → Underweight
Aug-20-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-13-20 Resumed Credit Suisse Neutral
Aug-04-20 Resumed Goldman Buy
Jul-27-20 Downgrade Cleveland Research Neutral → Underperform
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-10-20 Initiated Raymond James Mkt Perform
Dec-19-19 Upgrade BofA/Merrill Neutral → Buy
Nov-07-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-23-19 Initiated Barclays Overweight
Aug-26-19 Downgrade BofA/Merrill Buy → Neutral
Aug-15-19 Upgrade UBS Sell → Neutral
May-23-19 Initiated Guggenheim Neutral
Mar-18-19 Upgrade BofA/Merrill Neutral → Buy
Mar-13-19 Resumed Morgan Stanley Equal-Weight
Feb-12-19 Initiated William Blair Mkt Perform
Jan-23-19 Initiated UBS Sell
Jan-15-19 Initiated Argus Buy
Oct-15-18 Initiated Morgan Stanley Equal-Weight
View All

Elanco Animal Health Inc Stock (ELAN) Latest News

pulisher
02:00 AM

Elanco (ELAN) Stock Target Raised by Analyst Amid Favorable Quarter | ELAN Stock News - GuruFocus

02:00 AM
pulisher
01:57 AM

Elanco Animal Health (ELAN) Sees Strong Q1 Performance and Raises Outlook - GuruFocus

01:57 AM
pulisher
01:39 AM

Elanco (ELAN) Stock Trades Up, Here Is Why - Yahoo Finance

01:39 AM
pulisher
11:03 AM

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide - Benzinga

11:03 AM
pulisher
10:02 AM

Elanco Animal Health (ELAN) Raises Full-Year Revenue Outlook - GuruFocus

10:02 AM
pulisher
09:30 AM

Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

09:30 AM
pulisher
09:13 AM

Elanco Animal Health Inc SEC 10-Q Report - TradingView

09:13 AM
pulisher
08:38 AM

Transcript : Elanco Animal Health Incorporated, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com

08:38 AM
pulisher
08:36 AM

Elanco stock spikes after Q1 beat (ELAN:NYSE) - Seeking Alpha

08:36 AM
pulisher
08:05 AM

Elanco Animal Health Beats Q1 Estimates, Faces Revenue Growth ChallengesNews and Statistics - IndexBox

08:05 AM
pulisher
07:57 AM

Elanco (ELAN) Beats Earnings Estimates, Raises 2025 Revenue Guidance - GuruFocus

07:57 AM
pulisher
07:35 AM

Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

07:35 AM
pulisher
07:33 AM

Elanco Q1 2025 slides: Revenue guidance raised amid innovation-driven growth - Investing.com Canada

07:33 AM
pulisher
07:10 AM

Elanco Animal Health beats Q1 estimates, shares rise over 3% By Investing.com - Investing.com South Africa

07:10 AM
pulisher
07:09 AM

Elanco Animal Health beats Q1 estimates, shares rise over 3% - Investing.com Australia

07:09 AM
pulisher
07:03 AM

Elanco (ELAN) Revises 2025 Revenue Forecast and Affirms Profit Projections | ELAN Stock News - GuruFocus

07:03 AM
pulisher
06:53 AM

Elanco Animal Health Inc (ELAN) Q1 2025 Earnings: EPS of $0.13 Beats Estimate, Revenue at $1,193 Million Surpasses Expectations - GuruFocus

06:53 AM
pulisher
06:53 AM

Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance

06:53 AM
pulisher
06:47 AM

Elanco (ELAN) Reports Strong Q1 Revenue with Raised 2025 Guidance | ELAN Stock News - GuruFocus

06:47 AM
pulisher
06:45 AM

Elanco Animal Health Reports First Quarter 2025 Results | ELAN Stock News - GuruFocus

06:45 AM
pulisher
06:35 AM

Elanco Animal Health Reports First Quarter 2025 Results - TradingView

06:35 AM
pulisher
06:31 AM

Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

06:31 AM
pulisher
04:37 AM

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by First Trust Advisors LP - Defense World

04:37 AM
pulisher
May 06, 2025

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com

May 06, 2025
pulisher
May 06, 2025

Companion Animal Vaccine Market Is Booming So Rapidly 2025-2032 - openPR.com

May 06, 2025
pulisher
May 06, 2025

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings - FinancialContent

May 06, 2025
pulisher
May 05, 2025

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal - Benzinga

May 05, 2025
pulisher
May 05, 2025

Commit To Buy Elanco Animal Health At $8, Earn 13.1% Using Options - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Elanco Sells Xdemvy Royalty, Milestone Rights to Blackstone Affiliates for $295 Million - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Elanco Sells Royalty, Milestone Rights For Lotilaner In Human Health To Blackstone For $295 Mln Cash - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - PR Newswire

May 05, 2025
pulisher
May 02, 2025

Analyzing Ratios: Elanco Animal Health Inc (ELAN)’s Financial Story Unveiled - DWinneX

May 02, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Has $760,000 Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

May 02, 2025
pulisher
May 02, 2025

Cyromazine Market Deep Research Report with Forecast by 2032 | - openPR.com

May 02, 2025
pulisher
May 01, 2025

Elanco Animal Health Inc [ELAN] Shares Fall Approximately -28.51% Over the Year - knoxdaily.com

May 01, 2025
pulisher
Apr 30, 2025

Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Companion Animal Specialty Drugs Market Is Booming So Rapidly | Elanco, Dechra, Zomedica - openPR.com

Apr 30, 2025
pulisher
Apr 30, 2025

Mariner LLC Buys 24,901 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Elanco Board Sued Over Safety, FDA Setbacks for Dog Itch Drug - news.bloombergtax.com

Apr 29, 2025
pulisher
Apr 29, 2025

Elanco Animal Health Inc (ELAN) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

ELAN’s price-to-book ratio: An indicator of the company’s performance - uspostnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Elanco Animal Health Inc (ELAN) - Sete News

Apr 28, 2025
pulisher
Apr 28, 2025

Poultry Antibiotic Market Set to Witness Significant Growth - openPR.com

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 27, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Russell Investments Group Ltd. Decreases Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Wells Fargo & Company MN - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Elanco Animal Health Inc [ELAN] Records 200-Day SMA of $12.48 - knoxdaily.com

Apr 24, 2025

Elanco Animal Health Inc Stock (ELAN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$30.38
price up icon 0.07%
$80.49
price down icon 23.23%
$8.60
price up icon 1.42%
$121.61
price up icon 2.26%
$306.92
price up icon 4.03%
Cap:     |  Volume (24h):